| Introduction | Middle East Pharmaceutical Industries Co. announces signing a Memorandum of Understanding with BENTA SAS, to establish a strategic cooperation focused on strategic and innovative products within Saudi Arabia, in alignment with Vision 2030 and the National Industrial Strategy. |
| Memorandum Signing Date | 2025-11-25 Corresponding to 1447-06-04 |
| Counterparty | BENTA SAS (leading international pharmaceutical and biopharmaceutical manufacturer). |
| Memorandum Subject | Establish Strategic Partnership in Saudi Arabia. |
| Memorandum Duration | 2 Years |
| Related Parties | No |
| Financial Impact | No |
| Additional Information | The MoU sets a framework for collaboration in technology transfer, localization, and advanced technologies in manufacturing, combining Benta’s proven expertise and technical know-how with Avalon Pharma’s strong regulatory, manufacturing, and commercial foundation in the Kingdom. |
| Attached Documents | Attached Documents |
Qatar Index10,021.90-1.4%
DFM Index5,510.99-0.1%
TASI11,078.89-0.1%
Emirates NBD27.60-3.2%
Dubai Electricity & Water Authority2.65+0.4%
EMAAR12.10-0.4%
EMAARDEV13.750.0%
ADNOC GAS3.240.0%
First Abu Dhabi Bank17.38-1.0%
Emirates Telecom18.78+0.6%
Abu Dhabi Commercial Bank12.64+0.8%
ALRAJHI104.10-0.2%
SNB41.70-1.9%
MAADEN63.70-1.2%
SABIC58.40-0.9%
Boubyan Bank0.68-0.6%
GULF BANK0.33+0.6%
Commercial Bank Of Kuwait0.47-3.3%
Burgan Bank0.210.0%
QNB16.68-1.3%
Industries Qatar10.66-1.8%
Qatar Islamic Bank22.32-1.2%
Ooredoo12.19-3.5%